Global Venous Thromboembolism Prophylaxis Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Venous Thromboembolism Prophylaxis Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Lower Extremity
  • 1.2.3 Upper Extremity
• 1.3 Market by Application
  • 1.3.1 Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Venous Thromboembolism Prophylaxis Sales Estimates and Forecasts 2018-2029
• 2.2 Global Venous Thromboembolism Prophylaxis Revenue by Region
  • 2.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Venous Thromboembolism Prophylaxis Revenue by Region (2018-2023)
  • 2.2.3 Global Venous Thromboembolism Prophylaxis Revenue by Region (2024-2029)
  • 2.2.4 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2018-2029)
• 2.3 Global Venous Thromboembolism Prophylaxis Sales Estimates and Forecasts 2018-2029
• 2.4 Global Venous Thromboembolism Prophylaxis Sales by Region
  • 2.4.1 Global Venous Thromboembolism Prophylaxis Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Venous Thromboembolism Prophylaxis Sales by Region (2018-2023)
  • 2.4.3 Global Venous Thromboembolism Prophylaxis Sales by Region (2024-2029)
  • 2.4.4 Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Venous Thromboembolism Prophylaxis Sales by Manufacturers
  • 3.1.1 Global Venous Thromboembolism Prophylaxis Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Venous Thromboembolism Prophylaxis Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Venous Thromboembolism Prophylaxis in 2022
• 3.2 Global Venous Thromboembolism Prophylaxis Revenue by Manufacturers
  • 3.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by Venous Thromboembolism Prophylaxis Revenue in 2022
• 3.3 Global Key Players of Venous Thromboembolism Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global Venous Thromboembolism Prophylaxis Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Offered and Application
• 3.8 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Venous Thromboembolism Prophylaxis Sales by Type
  • 4.1.1 Global Venous Thromboembolism Prophylaxis Historical Sales by Type (2018-2023)
  • 4.1.2 Global Venous Thromboembolism Prophylaxis Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
• 4.2 Global Venous Thromboembolism Prophylaxis Revenue by Type
  • 4.2.1 Global Venous Thromboembolism Prophylaxis Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Venous Thromboembolism Prophylaxis Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
• 4.3 Global Venous Thromboembolism Prophylaxis Price by Type
  • 4.3.1 Global Venous Thromboembolism Prophylaxis Price by Type (2018-2023)
  • 4.3.2 Global Venous Thromboembolism Prophylaxis Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global Venous Thromboembolism Prophylaxis Sales by Application
  • 5.1.1 Global Venous Thromboembolism Prophylaxis Historical Sales by Application (2018-2023)
  • 5.1.2 Global Venous Thromboembolism Prophylaxis Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
• 5.2 Global Venous Thromboembolism Prophylaxis Revenue by Application
  • 5.2.1 Global Venous Thromboembolism Prophylaxis Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Venous Thromboembolism Prophylaxis Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
• 5.3 Global Venous Thromboembolism Prophylaxis Price by Application
  • 5.3.1 Global Venous Thromboembolism Prophylaxis Price by Application (2018-2023)
  • 5.3.2 Global Venous Thromboembolism Prophylaxis Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada Venous Thromboembolism Prophylaxis Market Size by Type
  • 6.1.1 US & Canada Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
  • 6.1.2 US & Canada Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
• 6.2 US & Canada Venous Thromboembolism Prophylaxis Market Size by Application
  • 6.2.1 US & Canada Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
  • 6.2.2 US & Canada Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
• 6.3 US & Canada Venous Thromboembolism Prophylaxis Market Size by Country
  • 6.3.1 US & Canada Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
  • 6.3.3 US & Canada Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Venous Thromboembolism Prophylaxis Market Size by Type
  • 7.1.1 Europe Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
  • 7.1.2 Europe Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
• 7.2 Europe Venous Thromboembolism Prophylaxis Market Size by Application
  • 7.2.1 Europe Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
  • 7.2.2 Europe Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
• 7.3 Europe Venous Thromboembolism Prophylaxis Market Size by Country
  • 7.3.1 Europe Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
  • 7.3.3 Europe Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Venous Thromboembolism Prophylaxis Market Size
  • 8.1.1 China Venous Thromboembolism Prophylaxis Sales (2018-2029)
  • 8.1.2 China Venous Thromboembolism Prophylaxis Revenue (2018-2029)
• 8.2 China Venous Thromboembolism Prophylaxis Market Size by Application
  • 8.2.1 China Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
  • 8.2.2 China Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Venous Thromboembolism Prophylaxis Market Size by Type
  • 9.1.1 Asia Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
  • 9.1.2 Asia Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
• 9.2 Asia Venous Thromboembolism Prophylaxis Market Size by Application
  • 9.2.1 Asia Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
  • 9.2.2 Asia Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
• 9.3 Asia Venous Thromboembolism Prophylaxis Sales by Region
  • 9.3.1 Asia Venous Thromboembolism Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia Venous Thromboembolism Prophylaxis Revenue by Region (2018-2029)
  • 9.3.3 Asia Venous Thromboembolism Prophylaxis Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Arjo
  • 11.1.1 Arjo Company Information
  • 11.1.2 Arjo Overview
  • 11.1.3 Arjo Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Arjo Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Arjo Recent Developments
• 11.2 Encompass Group
  • 11.2.1 Encompass Group Company Information
  • 11.2.2 Encompass Group Overview
  • 11.2.3 Encompass Group Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Encompass Group Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Encompass Group Recent Developments
• 11.3 Talley Group
  • 11.3.1 Talley Group Company Information
  • 11.3.2 Talley Group Overview
  • 11.3.3 Talley Group Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Talley Group Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Talley Group Recent Developments
• 11.4 MEGO AFEK
  • 11.4.1 MEGO AFEK Company Information
  • 11.4.2 MEGO AFEK Overview
  • 11.4.3 MEGO AFEK Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 MEGO AFEK Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 MEGO AFEK Recent Developments
• 11.5 Zenith Technical Innovations
  • 11.5.1 Zenith Technical Innovations Company Information
  • 11.5.2 Zenith Technical Innovations Overview
  • 11.5.3 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Zenith Technical Innovations Recent Developments
• 11.6 Normatec
  • 11.6.1 Normatec Company Information
  • 11.6.2 Normatec Overview
  • 11.6.3 Normatec Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 Normatec Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Normatec Recent Developments
• 11.7 Bio Compression Systems
  • 11.7.1 Bio Compression Systems Company Information
  • 11.7.2 Bio Compression Systems Overview
  • 11.7.3 Bio Compression Systems Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Bio Compression Systems Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Bio Compression Systems Recent Developments
• 11.8 ThermoTek USA
  • 11.8.1 ThermoTek USA Company Information
  • 11.8.2 ThermoTek USA Overview
  • 11.8.3 ThermoTek USA Venous Thromboembolism Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 ThermoTek USA Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 ThermoTek USA Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Venous Thromboembolism Prophylaxis Industry Chain Analysis
• 12.2 Venous Thromboembolism Prophylaxis Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Venous Thromboembolism Prophylaxis Production Mode & Process
• 12.4 Venous Thromboembolism Prophylaxis Sales and Marketing
  • 12.4.1 Venous Thromboembolism Prophylaxis Sales Channels
  • 12.4.2 Venous Thromboembolism Prophylaxis Distributors
• 12.5 Venous Thromboembolism Prophylaxis Customers

13 Market Dynamics

• 13.1 Venous Thromboembolism Prophylaxis Industry Trends
• 13.2 Venous Thromboembolism Prophylaxis Market Drivers
• 13.3 Venous Thromboembolism Prophylaxis Market Challenges
• 13.4 Venous Thromboembolism Prophylaxis Market Restraints

14 Key Findings in The Global Venous Thromboembolism Prophylaxis Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Lower Extremity
• Table 3. Major Manufacturers of Upper Extremity
• Table 4. Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 5. Global Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 6. Global Venous Thromboembolism Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
• Table 7. Global Venous Thromboembolism Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
• Table 8. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2018-2023)
• Table 9. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2024-2029)
• Table 10. Global Venous Thromboembolism Prophylaxis Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 11. Global Venous Thromboembolism Prophylaxis Sales by Region (2018-2023) & (K Units)
• Table 12. Global Venous Thromboembolism Prophylaxis Sales by Region (2024-2029) & (K Units)
• Table 13. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2018-2023)
• Table 14. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2024-2029)
• Table 15. Global Venous Thromboembolism Prophylaxis Sales by Manufacturers (2018-2023) & (K Units)
• Table 16. Global Venous Thromboembolism Prophylaxis Sales Share by Manufacturers (2018-2023)
• Table 17. Global Venous Thromboembolism Prophylaxis Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 18. Global Venous Thromboembolism Prophylaxis Revenue Share by Manufacturers (2018-2023)
• Table 19. Global Key Players of Venous Thromboembolism Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
• Table 20. Venous Thromboembolism Prophylaxis Price by Manufacturers 2018-2023 (US$/Unit)
• Table 21. Global Venous Thromboembolism Prophylaxis Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Venous Thromboembolism Prophylaxis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Prophylaxis as of 2022)
• Table 23. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Base Distribution and Headquarters
• Table 24. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Offered and Application
• Table 25. Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Date of Enter into This Industry
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
• Table 28. Global Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
• Table 29. Global Venous Thromboembolism Prophylaxis Sales Share by Type (2018-2023)
• Table 30. Global Venous Thromboembolism Prophylaxis Sales Share by Type (2024-2029)
• Table 31. Global Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
• Table 32. Global Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
• Table 33. Global Venous Thromboembolism Prophylaxis Revenue Share by Type (2018-2023)
• Table 34. Global Venous Thromboembolism Prophylaxis Revenue Share by Type (2024-2029)
• Table 35. Venous Thromboembolism Prophylaxis Price by Type (2018-2023) & (US$/Unit)
• Table 36. Global Venous Thromboembolism Prophylaxis Price Forecast by Type (2024-2029) & (US$/Unit)
• Table 37. Global Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
• Table 38. Global Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
• Table 39. Global Venous Thromboembolism Prophylaxis Sales Share by Application (2018-2023)
• Table 40. Global Venous Thromboembolism Prophylaxis Sales Share by Application (2024-2029)
• Table 41. Global Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
• Table 42. Global Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
• Table 43. Global Venous Thromboembolism Prophylaxis Revenue Share by Application (2018-2023)
• Table 44. Global Venous Thromboembolism Prophylaxis Revenue Share by Application (2024-2029)
• Table 45. Venous Thromboembolism Prophylaxis Price by Application (2018-2023) & (US$/Unit)
• Table 46. Global Venous Thromboembolism Prophylaxis Price Forecast by Application (2024-2029) & (US$/Unit)
• Table 47. US & Canada Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
• Table 48. US & Canada Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
• Table 49. US & Canada Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
• Table 50. US & Canada Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
• Table 51. US & Canada Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
• Table 52. US & Canada Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
• Table 53. US & Canada Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
• Table 54. US & Canada Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
• Table 55. US & Canada Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 56. US & Canada Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
• Table 57. US & Canada Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
• Table 58. US & Canada Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
• Table 59. US & Canada Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
• Table 60. Europe Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
• Table 61. Europe Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
• Table 62. Europe Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
• Table 63. Europe Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
• Table 64. Europe Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
• Table 65. Europe Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
• Table 66. Europe Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
• Table 67. Europe Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
• Table 68. Europe Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 69. Europe Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
• Table 70. Europe Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
• Table 71. Europe Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
• Table 72. Europe Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
• Table 73. China Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
• Table 74. China Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
• Table 75. China Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
• Table 76. China Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
• Table 77. China Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
• Table 78. China Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
• Table 79. China Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
• Table 80. China Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
• Table 81. Asia Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
• Table 82. Asia Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
• Table 83. Asia Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
• Table 84. Asia Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
• Table 85. Asia Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
• Table 86. Asia Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
• Table 87. Asia Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
• Table 88. Asia Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
• Table 89. Asia Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 90. Asia Venous Thromboembolism Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
• Table 91. Asia Venous Thromboembolism Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
• Table 92. Asia Venous Thromboembolism Prophylaxis Sales by Region (2018-2023) & (K Units)
• Table 93. Asia Venous Thromboembolism Prophylaxis Sales by Region (2024-2029) & (K Units)
• Table 94. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Type (2018-2023) & (K Units)
• Table 95. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Type (2024-2029) & (K Units)
• Table 96. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
• Table 97. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
• Table 98. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Application (2018-2023) & (K Units)
• Table 99. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Application (2024-2029) & (K Units)
• Table 100. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
• Table 101. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 103. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Country (2018-2023) & (K Units)
• Table 106. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales by Country (2024-2029) & (K Units)
• Table 107. Arjo Company Information
• Table 108. Arjo Description and Major Businesses
• Table 109. Arjo Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 110. Arjo Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Arjo Recent Developments
• Table 112. Encompass Group Company Information
• Table 113. Encompass Group Description and Major Businesses
• Table 114. Encompass Group Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 115. Encompass Group Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Encompass Group Recent Developments
• Table 117. Talley Group Company Information
• Table 118. Talley Group Description and Major Businesses
• Table 119. Talley Group Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 120. Talley Group Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Talley Group Recent Developments
• Table 122. MEGO AFEK Company Information
• Table 123. MEGO AFEK Description and Major Businesses
• Table 124. MEGO AFEK Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 125. MEGO AFEK Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. MEGO AFEK Recent Developments
• Table 127. Zenith Technical Innovations Company Information
• Table 128. Zenith Technical Innovations Description and Major Businesses
• Table 129. Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 130. Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Zenith Technical Innovations Recent Developments
• Table 132. Normatec Company Information
• Table 133. Normatec Description and Major Businesses
• Table 134. Normatec Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 135. Normatec Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Normatec Recent Developments
• Table 137. Bio Compression Systems Company Information
• Table 138. Bio Compression Systems Description and Major Businesses
• Table 139. Bio Compression Systems Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 140. Bio Compression Systems Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Bio Compression Systems Recent Developments
• Table 142. ThermoTek USA Company Information
• Table 143. ThermoTek USA Description and Major Businesses
• Table 144. ThermoTek USA Venous Thromboembolism Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 145. ThermoTek USA Venous Thromboembolism Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. ThermoTek USA Recent Developments
• Table 147. Key Raw Materials Lists
• Table 148. Raw Materials Key Suppliers Lists
• Table 149. Venous Thromboembolism Prophylaxis Distributors List
• Table 150. Venous Thromboembolism Prophylaxis Customers List
• Table 151. Venous Thromboembolism Prophylaxis Market Trends
• Table 152. Venous Thromboembolism Prophylaxis Market Drivers
• Table 153. Venous Thromboembolism Prophylaxis Market Challenges
• Table 154. Venous Thromboembolism Prophylaxis Market Restraints
• Table 155. Research Programs/Design for This Report
• Table 156. Key Data Information from Secondary Sources
• Table 157. Key Data Information from Primary Sources

List of Figures

• Figure 1. Venous Thromboembolism Prophylaxis Product Picture
• Figure 2. Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Venous Thromboembolism Prophylaxis Market Share by Type in 2022 & 2029
• Figure 4. Lower Extremity Product Picture
• Figure 5. Upper Extremity Product Picture
• Figure 6. Global Venous Thromboembolism Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global Venous Thromboembolism Prophylaxis Market Share by Application in 2022 & 2029
• Figure 8. Hospital
• Figure 9. Clinic
• Figure 10. Others
• Figure 11. Venous Thromboembolism Prophylaxis Report Years Considered
• Figure 12. Global Venous Thromboembolism Prophylaxis Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 13. Global Venous Thromboembolism Prophylaxis Revenue 2018-2029 (US$ Million)
• Figure 14. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 15. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Region (2018-2029)
• Figure 16. Global Venous Thromboembolism Prophylaxis Sales 2018-2029 ((K Units)
• Figure 17. Global Venous Thromboembolism Prophylaxis Sales Market Share by Region (2018-2029)
• Figure 18. US & Canada Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
• Figure 19. US & Canada Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
• Figure 20. Europe Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
• Figure 21. Europe Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
• Figure 22. China Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
• Figure 23. China Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
• Figure 24. Asia (excluding China) Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
• Figure 25. Asia (excluding China) Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
• Figure 26. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales YoY (2018-2029) & (K Units)
• Figure 27. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
• Figure 28. The Venous Thromboembolism Prophylaxis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 29. The Top 5 and 10 Largest Manufacturers of Venous Thromboembolism Prophylaxis in the World: Market Share by Venous Thromboembolism Prophylaxis Revenue in 2022
• Figure 30. Global Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 31. Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
• Figure 32. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
• Figure 33. Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
• Figure 34. Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
• Figure 35. US & Canada Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
• Figure 36. US & Canada Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
• Figure 37. US & Canada Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
• Figure 38. US & Canada Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
• Figure 39. US & Canada Venous Thromboembolism Prophylaxis Revenue Share by Country (2018-2029)
• Figure 40. US & Canada Venous Thromboembolism Prophylaxis Sales Share by Country (2018-2029)
• Figure 41. U.S. Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 42. Canada Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 43. Europe Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
• Figure 44. Europe Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
• Figure 45. Europe Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
• Figure 46. Europe Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
• Figure 47. Europe Venous Thromboembolism Prophylaxis Revenue Share by Country (2018-2029)
• Figure 48. Europe Venous Thromboembolism Prophylaxis Sales Share by Country (2018-2029)
• Figure 49. Germany Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 50. France Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 51. U.K. Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 52. Italy Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 53. Russia Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 54. China Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
• Figure 55. China Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
• Figure 56. China Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
• Figure 57. China Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
• Figure 58. Asia Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
• Figure 59. Asia Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
• Figure 60. Asia Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
• Figure 61. Asia Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
• Figure 62. Asia Venous Thromboembolism Prophylaxis Revenue Share by Region (2018-2029)
• Figure 63. Asia Venous Thromboembolism Prophylaxis Sales Share by Region (2018-2029)
• Figure 64. Japan Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 65. South Korea Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 66. China Taiwan Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 67. Southeast Asia Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 68. India Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 69. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
• Figure 70. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
• Figure 71. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
• Figure 72. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
• Figure 73. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Revenue Share by Country (2018-2029)
• Figure 74. Middle East, Africa and Latin America Venous Thromboembolism Prophylaxis Sales Share by Country (2018-2029)
• Figure 75. Brazil Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 76. Mexico Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 77. Turkey Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 78. Israel Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 79. GCC Countries Venous Thromboembolism Prophylaxis Revenue (2018-2029) & (US$ Million)
• Figure 80. Venous Thromboembolism Prophylaxis Value Chain
• Figure 81. Venous Thromboembolism Prophylaxis Production Process
• Figure 82. Channels of Distribution
• Figure 83. Distributors Profiles
• Figure 84. Bottom-up and Top-down Approaches for This Report
• Figure 85. Data Triangulation
• Figure 86. Key Executives Interviewed